<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Since DS usage is primarily self-initiated rather than based on clinicians’ recommendations, it renders unique challenges pertaining to efficacy, safety, and regulatory policies and practices to clinicians, consumers, and researchers 
 <sup class="sup">
  <xref rid="r1-2840637" ref-type="bibr" class="xref">1</xref>
 </sup>. In our set of data elements (
 <xref rid="t1-2840637" ref-type="table" class="xref">Table 1</xref>), the section “cautions” includes following facets: side effects, adverse reactions, contraindications, sensitivity reaction, interactions, toxicity/treatment, precautions and safety/interaction ratings. Our DS evaluation showed substantial coverage for various facet under “caution” section across all five databases. Comprehensive information on DS risks could be made available through our DS ontology after cross mapping each facet under “caution” section to the pertinent databases.
</p>
